Mitsubishi Chemical HoldingsTHE KAITEKI COMPANY

Achievement

Recent achievement results of the Group

Achievement FY2014

Performance Products
  • In September 2014, Mitsubishi Rayon developed and launched new elements and modules of hollow-fiber membranes for wastewater treatment that can save space and energy and has excellent detergency performance.
  • In November 2014, Astro developed and launched the artificial turf ASTRO GARDEN CEG Series using temperature suppressing materials.
  • In January 2015, Mitsubishi Plastics developed a film TECHBARRIER LS with high oxygen and vapor barrier properties and that can be used for the retort food packaging.
  • In February 2015, Mitsubishi Rayon acknowledged an order for PAN-based carbon fiber that would be used in the Structural Guide Vanes of a commercial aircraft engine for the first time in the world.
Industrial Materials
  • In January 2015, Taiyo Nippon Sanso successfully developed the high-purity copper nanoparticles that can be sintered at low temperature, based on the technology for synthesis of metal nanoparticles by oxy fueloxygen combustion.
  • In January 2015, Mitsubishi Chemical in conjunction with Mazda Motor Corporation developed a new grade of DURABIO, the highly functional transparent bio-based engineering plastic made of plant-derived isosorbide, that can be used for exterior design parts for automobiles without paint finish.
  • In March 2015, Mitsubishi Chemical developed the world’s first bio-derived high-performance polyols.
Health Care
  • In August 2014, Mitsubishi Tanabe Pharma started Phase 2 Clinical Trial Program of the seasonal influenza vaccine (the plant-based VLP vaccine) in the United States and Canada.
  • In September 2014, Mitsubishi Tanabe Pharma started Phase 3 Clinical Trial Program with Japanese patients for MT-2412, co-administration of Teneligliptin and Canaglifozin for Type 2 diabetes mellitus.

Achievement FY2013

Performance Products
  • In February 2013, Mitsubishi Plastics Infratec developed a new reinforcement method for pillars and beams using carbon fiber sheets.
  • In May 2013, Mitsubishi Rayon Textile developed the KIST material with a core-sheath structure.
  • In June 2013, Mitsubishi Chemical developed an inorganic separation membrane enabling energy savings of over 50% in the distillation process.
  • In July 2013, Mitsubishi Plastics Infratec developed special portable levee Daiya Rebi
  • In September 2013, Mitsubishi Plastics Infratec co-developed a next-generation thermal storage flooring system.
  • In October 2013, Mitsubishi Chemical established coating type organic photovoltaic (OPV) production technologies.
  • In January 2014, Mitsubishi Rayon developed high performance intermediate modulus carbon fiber Pyrofil MR70.
  • In January 2014, Mitsubishi Rayon developed composite structure wheels for automobiles.
  • In February 2014, Mitsubishi Chemical set a new world standard for carrier mobility using organic thin film transistors.
Industrial Materials
  • In May 2013, Du Pont and Mitsubishi Rayon developed artificial marble Bio-Surface.
  • In December 2013, Mitsubishi Chemical established the technology to mass-produce carbon black from plant oil with high efficiency.
Health Care
  • In May 2013, Mitsubishi Tanabe Pharma submitted an application for approval for domestic manufacturing and sales of Canagliflozin, an SGLT2 inhibitor for treating type 2 diabetes
  • In February 2014, Mitsubishi Tanabe Pharma started Global Phase 3 Clinical Trial Program, COGNITIV AD of Mt-4666 for Alzheimer's Disease

Achievement FY2012

Performance Products
  • In June 2012, Mitsubishi Chemical achieved longer life and greater efficiency for organic light emitting diode (OLED) lighting using a wet process.
  • In July 2012, Mitsubishi Rayon developed a space-saving, energy-efficient new hollow-fiber membrane, Sterapore, for purifying municipal and industrial wastewater by filtering and separating processed water and activated sludge.
  • In September 2012, Mitsubishi Chemical made progress with the development of organic photovoltaic (OPV) modules, achieving a world record of 11.7% conversion efficiency for organic thin-film single cells.
  • In October 2012, Mitsubishi Chemical developed tuning/dimming type OLED lighting panels with boosted brightness and power efficiency and launched sales through Mitsubishi Kagaku Media.
  • In January 2013, Mitsubishi Plastics developed the world’s longest industrial carbon roller, together with Sunray Koki K.K., which will make a great contribution to industrial efficiency on production lines for films, paper, and other products through its superior stable rotation capacities.
  • In February 2013, Mitsubishi Plastics developed a zeolite catalyst for selective catalytic reduction (SCR) systems, which uses urea to chemically reduce and detoxify nitrogen oxide (NOx) contained in exhaust gases.
Industrial Materials
  • In March 2013, Mitsubishi Chemical succeeded in making transparent continuous sheets of cellulose nanofibers in joint research with Oji Holdings Corporation, and decided to produce and start the supply of samples.
Health Care
  • In June 2012, Mitsubishi Tanabe Pharma received manufacturing and sales approval in Japan for Tenelia to be used in the treatment of type-2 diabetes.
  • In March 2013, manufacturing and sales approval in the United States was given for TA-7284, developed by Mitsubishi Tanabe Pharma and licensed to Janssen Pharmaceuticals, Inc., to be used in the treatment of type-2 diabetes.
  • In January 2013, Mitsubishi Tanabe Pharma received manufacturing and sales approval in Europe for MCI-196 (BindRen) to be used in the treatment of hyperphosphatemia.
  • In February 2013, Mitsubishi Chemical Medience developed a highly sensitive analytical method for detecting darbepoetin alfa in human urine by means of liquid chromatography-tandem mass spectrometry for doping control.

Achievement FY2011

Performance Products
  • In May 2011, Mitsubishi Chemical achieved the highest light efficiency of 52 lumen/watt and 20,000 hours in the brightness half-life for organic light emitting diode (OLED) lighting using a wet-process, together with Pioneer Corporation.
  • In June 2011, Mitsubishi Chemical made progress with the development of organic photovoltaic (OPV) modules achieving the world’s highest conversion efficiency of 10.1% for organic thin-film single cells (11% as of May 2012).
  • Mitsubishi Chemical established mass production pilot facilities at its Mizushima Plant to realize low cost mass production operations of gallium nitride substrates to be used for white LED (Light Emitting Diode) and others.
  • In July 2011, Mitsubishi Plastics commercialized the industry’s first high barrier PET bottles to be used with sake in collaboration with HAKUTSURU SAKE Brewing Co., Ltd.
  • In July 2011, Mitsubishi Rayon and Mitsubishi Rayon Textile developed heat shield polyester fiber materials in collaboration with MIZUNO Corporation, and launched joint sales operations.
  • In November 2011, MKV Dream (currently, Mitsubishi Plastics Agri Dream) started a verification test of a solar powered plant factory in China in collaboration with the agricultural co-operative in Jiangsu, China.
  • In November 2011, Mitsubishi Plastics developed, in collaboration with Union Industry Co., Ltd., a compact adsorption chiller having high power saving and energy saving performances by using “AQSOA™,” a zeolite-based vapor-adsorbent material that had been developed by Mitsubishi Plastics. The two companies launched joint sales operations from January 2012.
  • In December 2011, Mitsubishi Plastics developed cost-competitive high heat-resistant separators to be used for lithium ion secondary batteries.
Industrial Materials
  • In February 2012, Mitsubishi Chemical started constructing a mass production facility (improving its existing facility) of plant-based isosorbide polymers at its Kurosaki Branch.
  • In November 2011, Mitsubishi Rayon and its subsidiary, Lucite International Group, started developing production technologies related to sustainable MMA (Methyl Methacrylate) monomers derived from new bio based routes.
Health Care
  • In May 2011, Mitsubishi Tanabe Pharma obtained an approval in Japan for additional indication for a selective β1 antagonist, MAINTATE for chronic heart failure, and launched sales from June 2011.
  • In June 2011, Mitsubishi Chemical Medience obtained an approval from the U.S. Food and Drug Administration (FDA) for PATHFAST cTnI (cardiac Troponin I) diagnostic test to be used as a myocardial infarction diagnostic index.
  • In August 2011, Mitsubishi Tanabe Pharma obtained an approval in Japan for partial changes of dosage and usage in Crohn’s disease for an anti-human TNF-α monoclonal-antibody, Remicade.
  • In August 2011, Mitsubishi Tanabe Pharma submitted an application for an approval for manufacturing and marketing of MP-513 (generic name: teneligliptin), a type 2 diabetes treatment that had been developed by Mitsubishi Tanabe Parma in Japan.
  • In August 2011, Mitsubishi Tanabe Pharma submitted an application for an approval for manufacturing and marketing in Europe regarding MCI-196 (generic name: colestilan) developed by Mitsubishi Tanabe Pharma to be used as a treatment drug for hyperphosphatemia.
  • In September 2011, Mitsubishi Tanabe Pharma obtained an approval for manufacturing and marketing in Japan regarding IMUSERA capsules, an oral dosing multiple sclerosis treatment, and TELAVIC, an antiviral chronic hepatitis C, and started selling them from November 2011.

※Mitsubishi Chemical Corporation, Mitsubishi Plastics, Inc., and Mitsubishi Rayon Co., Ltd. were integrated together, thereby launching a new Mitsubishi Chemical Corporation on April 1, 2017.
It should be noted that the information may contain the former company names.